Exclusive

Publication

Byline

Location

18 से 21 अगस्त के बीच जियो हॉटस्टार पर आ रही हैं ये फिल्में और सीरीज, अक्षय कुमार करेंगे धमाका

नई दिल्ली, अगस्त 17 -- आने वाला हफ्ता जियो हॉटस्टार की ऑडियंस के लिए खास होने वाला है। क्राइम, ड्रामा और थ्रिलर से भरी सीरीज और फिल्में रिलीज होने वाली हैं। अगर अपना आने वाला हफ्ता खास बनाना चाहते हैं... Read More


"Positions, titles change; but once BJYM, always BJYM": Tejasvi Surya pens heartfelt note after Hemang Joshi announced as new Yuva Morcha chief

Bengaluru, Aug. 17 -- The Bharatiya Janata Party (BJP) leader Tejasvi Surya on Tuesday expressed gratitude to the party's top leadership and Bharatiya Janata Yuva Morcha (BJYM) workers as he reflected... Read More


Bagmati chief minister set to resign ahead of floor test

Makawanpur, Aug. 17 -- Bagmati Province Chief Minister Indra Bahadur Baniya is preparing to resign on Monday after the CPN-UML withdrew its support for his government, leaving it in the minority. The... Read More


Black hole 'star': What we know about brand-new mysterious object that isn't really a star

New Delhi, Aug. 17 -- Astronomers claim to have discovered what NASA describes as a "strange cosmic object that shines like a star but appears to be powered by a rapidly feeding black hole." The objec... Read More


Singapore Clinical Trial: An Open-label, Randomized, Controlled Phase 3 Study of Disitamab Vedotin in Combination with Pembrolizumab Versus Chemotherapy in Subjects with Previously Untreated Locally Advanced or Metastatic Urothelial Carcinoma that Expresses HER2 (IHC 1+ and Greater)

Singapore, Aug. 17 -- The Health Sciences Authority received information related to the study titled 'An Open-label, Randomized, Controlled Phase 3 Study of Disitamab Vedotin in Combination with Pembr... Read More


Singapore Clinical Trial: A Randomized, Open-label, Phase 3 Study of Rina-S ± Bevacizumab Versus Investigator's Choice of Platinum-Based Chemotherapy ± Bevacizumab as 2L Treatment in Participants With Recurrent Platinum-Sensitive Ovarian Cancer

Singapore, Aug. 17 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Open-label, Phase 3 Study of Rina-S ± Bevacizumab Versus Investigator's Choice of Pl... Read More


Singapore Clinical Trial: ROSETTA Lung-201: A Randomized, Multicenter, Open-label Phase 3 Study of Pumitamig Monotherapy Compared to Durvalumab in Participants with Unresectable Stage III NSCLC Without Progression After Platinum-based Concurrent Chemoradiation Therapy.

Singapore, Aug. 17 -- The Health Sciences Authority received information related to the study titled 'ROSETTA Lung-201: A Randomized, Multicenter, Open-label Phase 3 Study of Pumitamig Monotherapy Com... Read More


Singapore Clinical Trial: A Phase 2, Randomized, Open-Label Study of VVD-133214 in Combination with Pembrolizumab compared with Pembrolizumab monotherapy in participants with advanced colorectal adenocarcinoma (CRC) harboring microsatellite instability (MSI) and/or deficient mismatch repair (DMMR)

Singapore, Aug. 17 -- The Health Sciences Authority received information related to the study titled 'A Phase 2, Randomized, Open-Label Study of VVD-133214 in Combination with Pembrolizumab compared w... Read More


Singapore Clinical Trial: A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Investigator Choice of Chemotherapy (modified FOLFIRINOX or Gemcitabine plus Nab-paclitaxel) with or without Zoldonrasib (RMC 9805) as First-line Treatment in Patients with Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma (RASolute 305)

Singapore, Aug. 17 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Investigator Choice of Chemothera... Read More


Singapore Clinical Trial: A Phase 1, Investigator- and Participant-Blinded, Placebo-Controlled, Randomized, Multiple-Dose Study to Evaluate the Gastric Emptying Delay, Pharmacokinetics, Safety, and Tolerability of Eloralintide in Participants with Obesity or Overweight

Singapore, Aug. 17 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Investigator- and Participant-Blinded, Placebo-Controlled, Randomized, Multiple-Dose St... Read More